Skip to main content
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. — Investor Relations & Filings

Ticker · PCRX ISIN · US6951271005 LEI · 549300P56LERYBDHCF69 US Manufacturing
Filings indexed 1,216 across all filing types
Latest filing 2024-01-19 Major Shareholding Noti…
Country US United States of America
Listing US PCRX

About Pacira BioSciences, Inc.

https://www.pacira.com/

Pacira BioSciences, Inc. is a pharmaceutical company that develops, commercializes, and manufactures non-opioid pain management and regenerative health solutions. The company's mission is to provide alternatives to opioids by delivering innovative, precise, and targeted therapies. Its products and research pipeline address a diverse range of needs, including postsurgical, chronic, and musculoskeletal pain. Pacira is also focused on developing advanced solutions, including gene therapy, to address unmet needs in pain management.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2024
Major Shareholding Notification
2024-01-19 English
FORM 4
Director's Dealing
2024-01-04 English
FORM 4
Director's Dealing
2024-01-04 English
FORM 4
Director's Dealing
2024-01-04 English
FORM 3
Director's Dealing
2024-01-04 English
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated January 4, 2024, reporting preliminary unaudited revenue for the fourth quarter and full year ended December 31, 2023. It includes a press release as an exhibit. The document is short (3412 characters) and primarily announces financial results without detailed financial statements or substantive analysis. It is an initial announcement of quarterly/periodical financial results, consistent with an Earnings Release (ER).
2024-01-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.